Our Team
Jordan Pappas has experience in a range of industrial and academic chemist roles including process, polymer, quantum, and analytical chemistry. Jordan’s career started in 2016, working in process chemistry and product development at Resinate Materials Group, which aimed to recycle post-consumer and post-industrial plastic waste into new high-performance polymer products using recycled and/or biorenewable materials in polymer synthesis. Resinate was successfully sold to Carlisle Construction Materials in 2020, at which point Jordan was hired by Carlisle to work alongside their engineers to further transition Resinate’s technology into full-scale commercial production of recycled polymer products. Jordan is listed as inventor on one patent from his time at Carlisle involving the interactions between epoxides and carboxylic acids and their use in manufacturing polyester polymers.
During the same time at Resinate, Jordan also held a research assistant position at the University of Michigan’s computational and quantum chemistry department from 2018 to 2020. His research aimed at providing benchmark computational /quantum research on interactions between greenhouse gasses and water molecules in hopes of aiding in the understanding of the threats greenhouse gas pockets in oceans may have on climate as ocean temperatures rise. Jordan was awarded the Distinguished Research Award by the University of Michigan in 2019 for this work and presented the research at the A.C.S. regional conference in Midland, MI in 2019 as well. This research is pending publication.
Jordan then transitioned his career into analytical chemistry. After a brief contract position analyzing developmental automotive products in 2021, he then started as research associate with Penrose Therapeutx where he provided analytical assistance during drug discovery and development for cancer treatment.
Let’s work together to change cancer’s trajectory
We look forward to talking to you. You may contact us for more information.
Let’s work together
to change cancer’s trajectory
We look forward to talking to you. You may contact us for more information.